- Home
- AXSM vs LUMN Comparison
AXSM vs LUMN Comparison
Compare AXSM & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LUMN
- Stock Information
- Founded
- AXSM 2012
- LUMN 1968
- Country
- AXSM United States
- LUMN United States
- Employees
- AXSM N/A
- LUMN N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LUMN Telecommunications Equipment
- Sector
- AXSM Health Care
- LUMN Telecommunications
- Exchange
- AXSM Nasdaq
- LUMN Nasdaq
- Market Cap
- AXSM 5.9B
- LUMN 5.1B
- IPO Year
- AXSM 2015
- LUMN 1972
- Fundamental
- Price
- AXSM $131.96
- LUMN $10.16
- Analyst Decision
- AXSM Strong Buy
- LUMN Buy
- Analyst Count
- AXSM 19
- LUMN 7
- Target Price
- AXSM $174.47
- LUMN $5.34
- AVG Volume (30 Days)
- AXSM 465.7K
- LUMN 16.3M
- Earning Date
- AXSM 11-03-2025
- LUMN 10-30-2025
- Dividend Yield
- AXSM N/A
- LUMN N/A
- EPS Growth
- AXSM N/A
- LUMN N/A
- EPS
- AXSM N/A
- LUMN N/A
- Revenue
- AXSM $495,033,000.00
- LUMN $12,824,000,000.00
- Revenue This Year
- AXSM $63.76
- LUMN N/A
- Revenue Next Year
- AXSM $54.57
- LUMN N/A
- P/E Ratio
- AXSM N/A
- LUMN N/A
- Revenue Growth
- AXSM 69.83
- LUMN N/A
- 52 Week Low
- AXSM $75.56
- LUMN $3.01
- 52 Week High
- AXSM $139.13
- LUMN $10.33
- Technical
- Relative Strength Index (RSI)
- AXSM 61.56
- LUMN 82.75
- Support Level
- AXSM $127.17
- LUMN $6.76
- Resistance Level
- AXSM $136.23
- LUMN $7.31
- Average True Range (ATR)
- AXSM 4.18
- LUMN 0.50
- MACD
- AXSM 0.50
- LUMN 0.29
- Stochastic Oscillator
- AXSM 74.50
- LUMN 95.57
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LUMN Lumen Technologies Inc.
With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 have shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen has announced the sale of its consumer fiber network, but will maintain and harvest its legacy consumer copper network.